Appendix 3Z Final Director's Interest Notice Appendix 3Z Final Director's Interest Notice

Rule 3.19A.3

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity BENITEC LIMITED ABN 64 068 943 662

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director

Dr John Chiplin

Date of last notice

6 October 2016

Date that director ceased to be director

23 October 2017

Part 1 - Director's relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Number & class of securities

200,000 Ordinary shares

840,000 Unlisted Options exercise price $0.77 expiry 12 November 2020

+ See chapter 19 for defined terms.

11/3/2002 Appendix 3Z Page 1

Appendix 3Z Final Director's Interest Notice Part 2 - Director's relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest

Note: Provide details of the circumstances giving rise to the relevant interest

Nil

Number & class of securities

Nil

Part 3 - Director's interests in contracts

Detail of contract

Not applicable

Nature of interest

Name of registered holder (if issued securities)

No. and class of securities to which interest relates

Appendix 3Z Page 2

Benitec Biopharma Ltd. published this content on 24 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 October 2017 00:07:01 UTC.

Original documenthttp://blt.live.irmau.com/irm/PDF/1895_0/FinalDirector39sInterestNotice

Public permalinkhttp://www.publicnow.com/view/03B27361D4AEB366B79288435C27292EDB16E362